Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002114608 | SCV002444477 | likely benign | not provided | 2024-07-06 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003070597 | SCV003717173 | uncertain significance | Inborn genetic diseases | 2021-10-26 | criteria provided, single submitter | clinical testing | The c.655C>A (p.L219M) alteration is located in exon 7 (coding exon 6) of the PRPF31 gene. This alteration results from a C to A substitution at nucleotide position 655, causing the leucine (L) at amino acid position 219 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Prevention |
RCV004757525 | SCV005352957 | likely benign | PRPF31-related disorder | 2024-04-17 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |